Targeting the PAS-A domain of HIF-1alpha for development of small molecule inhibitors of HIF-1 - PubMed (original) (raw)
. 2006 Aug;5(16):1847-53.
doi: 10.4161/cc.5.16.3019. Epub 2006 Aug 15.
Affiliations
- PMID: 16861921
- DOI: 10.4161/cc.5.16.3019
Targeting the PAS-A domain of HIF-1alpha for development of small molecule inhibitors of HIF-1
Eun Jung Park et al. Cell Cycle. 2006 Aug.
Abstract
Hypoxia inducible factor-1 (HIF-1) is a master regulator of cellular adaptation to oxygen deprivation and activates transcription of genes involved in tumor metabolism, angiogenesis, invasion and metastasis, all of which are implicated in cancer progression. Several domains of HIF-1alpha mediate protein-protein interaction, which is essential for the formation of the active heterodimer with HIF-1beta. Targeting specific domains of HIF-1alpha might lead to the identification of more selective inhibitors. HIF-1alpha and HIF-1beta contain two Per-Arnt-Sim (PAS) domains, A and B, both of which appear to be important for heterodimer formation. In an attempt to identify small molecule inhibitors of the PAS-A domain of HIF-1 we expressed proteins containing amino acids 86-165 of HIF-1alpha and amino acids 159-240 of HIF-1beta fused to a His or FLAG tag, respectively. Expressed proteins retained functional activity as indicated by in vitro immunoprecipitation experiments and activation of luciferase expression in a mammalian two-hybrid system. Interestingly, over-expression of HIF-1alpha-PAS-A domain was sufficient to abrogate hypoxic induction of HIF-1-dependent luciferase expression, supporting its potential role as drug target. An ELISA based on the interaction between FLAG-HIF-1beta-PAS-A and HIF-1alpha-PAS-A-His was developed and used to screen libraries of synthetic compounds. NSC 50352 specifically inhibited PAS-A-dependent interaction between HIF-1alpha and HIF-1beta, but not the interaction mediated by unrelated domains. However, NSC 50352 was devoid of activity in cell-based assays. Our results provide proof-of-principle that the PAS-A domain of HIF-1alpha is a valid target for development of small molecule inhibitors.
Similar articles
- Coactivators necessary for transcriptional output of the hypoxia inducible factor, HIF, are directly recruited by ARNT PAS-B.
Partch CL, Gardner KH. Partch CL, et al. Proc Natl Acad Sci U S A. 2011 May 10;108(19):7739-44. doi: 10.1073/pnas.1101357108. Epub 2011 Apr 21. Proc Natl Acad Sci U S A. 2011. PMID: 21512126 Free PMC article. - The role of the aryl hydrocarbon receptor nuclear translocator (ARNT) in hypoxic induction of gene expression. Studies in ARNT-deficient cells.
Wood SM, Gleadle JM, Pugh CW, Hankinson O, Ratcliffe PJ. Wood SM, et al. J Biol Chem. 1996 Jun 21;271(25):15117-23. doi: 10.1074/jbc.271.25.15117. J Biol Chem. 1996. PMID: 8662957 - Cloning, characterization, hypoxia and heat shock response of hypoxia inducible factor-1 (HIF-1) from the small abalone Haliotis diversicolor.
Cai X, Huang Y, Zhang X, Wang S, Zou Z, Wang G, Wang Y, Zhang Z. Cai X, et al. Gene. 2014 Jan 25;534(2):256-64. doi: 10.1016/j.gene.2013.10.048. Epub 2013 Nov 7. Gene. 2014. PMID: 24211325 - Hypoxia-inducible factor-1 in human breast and prostate cancer.
Kimbro KS, Simons JW. Kimbro KS, et al. Endocr Relat Cancer. 2006 Sep;13(3):739-49. doi: 10.1677/erc.1.00728. Endocr Relat Cancer. 2006. PMID: 16954428 Review. - Hypoxia inducible factor pathways as targets for functional foods.
Losso JN, Bawadi HA. Losso JN, et al. J Agric Food Chem. 2005 May 18;53(10):3751-68. doi: 10.1021/jf0479719. J Agric Food Chem. 2005. PMID: 15884793 Review.
Cited by
- Conducive target range of breast cancer: Hypoxic tumor microenvironment.
Cheng W, Xiao X, Liao Y, Cao Q, Wang C, Li X, Jia Y. Cheng W, et al. Front Oncol. 2022 Sep 26;12:978276. doi: 10.3389/fonc.2022.978276. eCollection 2022. Front Oncol. 2022. PMID: 36226050 Free PMC article. Review. - SEPT9_i1 is required for the association between HIF-1α and importin-α to promote efficient nuclear translocation.
Golan M, Mabjeesh NJ. Golan M, et al. Cell Cycle. 2013 Jul 15;12(14):2297-308. doi: 10.4161/cc.25379. Cell Cycle. 2013. PMID: 24067372 Free PMC article. - Motif mediated protein-protein interactions as drug targets.
Corbi-Verge C, Kim PM. Corbi-Verge C, et al. Cell Commun Signal. 2016 Mar 2;14:8. doi: 10.1186/s12964-016-0131-4. Cell Commun Signal. 2016. PMID: 26936767 Free PMC article. Review. - Natural flavonoid Orientin restricts 5-Fluorouracil induced cancer stem cells mediated angiogenesis by regulating HIF1α and VEGFA in colorectal cancer.
Ghosh R, Bhowmik A, Biswas S, Samanta P, Sarkar R, Pakhira S, Mondal M, Hajra S, Saha P. Ghosh R, et al. Mol Med. 2025 Mar 5;31(1):85. doi: 10.1186/s10020-024-01032-1. Mol Med. 2025. PMID: 40045186 Free PMC article. - A cell-penetrating peptide suppresses the hypoxia inducible factor-1 function by binding to the helix-loop-helix domain of the aryl hydrocarbon receptor nuclear translocator.
Wang Y, Thompson JD, Chan WK. Wang Y, et al. Chem Biol Interact. 2013 Apr 25;203(2):401-11. doi: 10.1016/j.cbi.2013.02.003. Epub 2013 Feb 27. Chem Biol Interact. 2013. PMID: 23454269 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources